Detalles de la búsqueda
1.
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.
Ann Oncol
; 34(1): 91-100, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209981
2.
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer.
BMC Cancer
; 22(1): 820, 2022 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35897060
3.
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial.
Strahlenther Onkol
; 197(1): 8-18, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32914237
4.
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.
Ann Oncol
; 30(12): 1959-1968, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562758
5.
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
BMC Cancer
; 19(1): 979, 2019 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31640628
6.
Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists' clinical deliberation.
BMC Cancer
; 17(1): 780, 2017 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29162047
7.
Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group.
Ann Oncol
; 27(9): 1746-53, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27358379
8.
[ASCO-update 2015 - highlights of the 51. meeting of the american society of clinical oncology/ASCO 2015]. / ASCO-Update 2015 - Neuigkeiten vom 51. Meeting der American Society of Clinical Oncology/ASCO 2015.
Z Gastroenterol
; 54(2): 167-72, 2016 Feb.
Artículo
en Alemán
| MEDLINE | ID: mdl-26854837
9.
[Clinically relevant, gender-specific differences in colorectal carcinoma (CRC)]. / Klinisch relevante, geschlechtsspezifische Unterschiede beim kolorektalen Karzinom (KRK).
Z Gastroenterol
; 53(8): 782-8, 2015 Aug.
Artículo
en Alemán
| MEDLINE | ID: mdl-26284326
10.
[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm]. / Kolorektales Karzinom bei V.âa. Lynch-Syndrom: ein interdisziplinärer Algorithmus.
Zentralbl Chir
; 140(6): 591-9, 2015 Dec.
Artículo
en Alemán
| MEDLINE | ID: mdl-25372301
11.
Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy.
Z Gastroenterol
; 52(12): 1394-401, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25474278
12.
Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group.
ESMO Open
; 9(4): 102944, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503144
13.
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group.
Ann Oncol
; 24(6): 1580-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23463625
14.
Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group.
Ann Oncol
; 24(12): 3051-5, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24130263
15.
Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer-a study in AIO oncologists.
ESMO Open
; 8(1): 100761, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638708
16.
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.
Br J Cancer
; 106(6): 1033-8, 2012 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22374460
17.
Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Z Gastroenterol
; 49(10): 1398-406, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21964893
18.
[Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: clinical validation of a histopathological scoring system and preoperative risk assessment]. / Chemotherapieassoziierte Leberveränderungen bei Patienten mit kolorektalem Karzinom und operativer Entfernung von Lebermetastasen: Evaluierung eines histopathologischen Scores und Erhebung präoperativer Risikofaktoren.
Z Gastroenterol
; 49(10): 1407-11, 2011 Oct.
Artículo
en Alemán
| MEDLINE | ID: mdl-21964894
19.
[Steatohepatitis after chemotherapy for colorectal liver metastases (CASH)]. / Steatohepatitis bei der Chemotherapie kolorektaler Lebermetastasen (CASH).
Pathologe
; 32(4): 330-5, 2011 Jul.
Artículo
en Alemán
| MEDLINE | ID: mdl-21681471
20.
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' method.
Eur J Cancer
; 146: 95-106, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588150